When to Bank on Banks
Effort directed at a new post has been fleeting. It is a pleasure that the buyout of Achillion Pharmaceuticals closed so quickly. However, beyond that, pharmaceuticals are frequently the object… Read more »
Effort directed at a new post has been fleeting. It is a pleasure that the buyout of Achillion Pharmaceuticals closed so quickly. However, beyond that, pharmaceuticals are frequently the object… Read more »
Political issues can by nature be such that some won’t discuss them. Topics are under-emphasized, maybe for valid reasons. However, prevailing reasoning can then be contorted, or even manipulated years… Read more »
With some sensitivity toward the haphazard use of the word philosophy, let’s try and think of the term ‘operating principles.’ We all have different characteristics, abilities and skills. If one… Read more »
What we have is effectively a newsletter about insights or issues that become evident through following financial markets and there is leeway and freedom of methodology. There are in fact… Read more »
There are not any top picks, or pans, for 2020 at hand. The modus operandi here tends to be predicated upon our stock market (VOO) gaining most of the time, amid… Read more »
Perspectives on biotechnology vary. Interest often begins with the hope that an effective treatment will be found for illness. Beneath that, there can be true innovation as existing knolwedge and… Read more »
There are web sites that make money. Arguably, when their topic is publicly-traded stocks, not necessarily economics, accuracy should be the only thing anyone pays for. However, chances are that… Read more »
There are all sorts of known methods of investing and trading. Short selling is within the latter category; and there must be at least as many parties who have ineffectual… Read more »
There is an ongoing crisis in Argentina. The nation is in a difficult fiscal and economic situation: “with ballooning inflation, a plunging peso, a poverty rate that has risen from… Read more »
In a previous post, a negative description of Verizon (VZ) is presented. Issues involve questions about the capabilities of the CEO as well as caution toward prospects for the rest… Read more »